NEURAXPHARM UK LIMITED

Active Cardiff

Wholesale of pharmaceutical goods

9 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
N

NEURAXPHARM UK LIMITED

Wholesale of pharmaceutical goods

Founded 16 Aug 2017 Active Cardiff, United Kingdom 9 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods

Previous Company Names

NUPHARM UK HOLDING LIMITED 16 Aug 2017 — 14 Nov 2017
Accounts Submitted 10 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 3 Sept 2025 Next due 29 Aug 2026 4 months remaining
Net assets £687K £304K 2023 year on year
Total assets £13M £5M 2023 year on year
Total Liabilities £12M £5M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Tudor House 16 Cathedral Road Cardiff CF11 9LJ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEURAXPHARM UK LIMITED (10918621), an active life sciences and medical technology company based in Cardiff, United Kingdom. Incorporated 16 Aug 2017. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£820.98k

Increased by £583.41k (+246%)

Net Assets

£686.95k

Increased by £304.36k (+80%)

Total Liabilities

£12.11M

Increased by £4.73M (+64%)

Turnover

£19.93M

Employees

9

Increased by 2 (+29%)

Debt Ratio

95%

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 300,000 Shares £300k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Dec 2018300,000£300k£1

Officers

Officers

1 active 2 resigned
Status
Mark Anthony SlaterDirectorBritishUnited Kingdom4910 Oct 2022Active

Shareholders

Shareholders (1)

Neuraxpharm Midco S.c.a.
100.0%
305,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 16 Dec 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

NEURAXPHARM UK LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Sept 2025AccountsAnnual accounts made up to 2024-12-31
3 Sept 2025Confirmation StatementConfirmation statement made on 2025-08-15 with no updates
30 Sept 2024AccountsAnnual accounts made up to 2023-12-31
2 Sept 2024Confirmation StatementConfirmation statement made on 2024-08-15 with no updates
21 Feb 2024Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
10 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

3 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-08-15 with no updates

30 Sept 2024 Accounts

Annual accounts made up to 2023-12-31

2 Sept 2024 Confirmation Statement

Confirmation statement made on 2024-08-15 with no updates

21 Feb 2024 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

Recent Activity

Latest Activity

Annual accounts made up to 2024-12-31

7 months ago on 10 Sept 2025

Confirmation statement made on 2025-08-15 with no updates

7 months ago on 3 Sept 2025

Annual accounts made up to 2023-12-31

1 years ago on 30 Sept 2024

Confirmation statement made on 2024-08-15 with no updates

1 years ago on 2 Sept 2024

Withdrawal Of A Person With Significant Control Statement

2 years ago on 21 Feb 2024